Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gary Cutter

Showing results (21-30 of 333) with videos related to

Pageof 34
Sort By:
Muscle & Nerve|November 2, 2022
The best and worst of times in therapy development for myasthenia gravisMichael Benatar, Gary Cutter, Henry J Kaminski
Neurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary Cutter
Kidney360|April 4, 2022
Arteriovenous Fistula Nonmaturation: What's the Immune System Got to Do with It?Crystal A Farrington, Gary Cutter, Michael Allon
Muscle & Nerve|April 13, 2011
Practice parameters and focusing research: plasma exchange for myasthenia gravisHenry J Kaminski, Gary Cutter, Robert Ruff
Biometrics|March 2, 2005
Assessing accuracy of mammography in the presence of verification bias and intrareader correlationYingye Zheng, William E Barlow, Gary Cutter
Current Opinion in Neurology|April 6, 2019
Multiple sclerosis: clinical trial design 2019Matteo Pardini, Gary Cutter, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
An enrichment strategy for clinical trials in SPMSMarcus W Koch, Luanne Metz, Gary Cutter
Journal of Computer Assisted Tomography|July 19, 2013
National variation of technical factors in computed tomography of the headDavid Thickman, Guoqiao Wang, Jaleh White, et al.
Therapeutic Advances in Neurological Disorders|July 24, 2018
Clinical trials in multiple sclerosis: milestonesYinan Zhang, Amber Salter, Gary Cutter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 15, 2017
Which symptoms contribute the most to patients' perception of health in multiple sclerosis?Rivka Green, Gary Cutter, Michael Friendly, et al.
Pageof 34

Showing results (21-30 of 333) with videos related to

Sort By:
Pageof 34
Muscle & Nerve|November 2, 2022
The best and worst of times in therapy development for myasthenia gravisMichael Benatar, Gary Cutter, Henry J Kaminski
Neurology|December 10, 2003
Effect of relapses on development of residual deficit in multiple sclerosisFred D Lublin, Monika Baier, Gary Cutter
Kidney360|April 4, 2022
Arteriovenous Fistula Nonmaturation: What's the Immune System Got to Do with It?Crystal A Farrington, Gary Cutter, Michael Allon
Muscle & Nerve|April 13, 2011
Practice parameters and focusing research: plasma exchange for myasthenia gravisHenry J Kaminski, Gary Cutter, Robert Ruff
Biometrics|March 2, 2005
Assessing accuracy of mammography in the presence of verification bias and intrareader correlationYingye Zheng, William E Barlow, Gary Cutter
Current Opinion in Neurology|April 6, 2019
Multiple sclerosis: clinical trial design 2019Matteo Pardini, Gary Cutter, Maria Pia Sormani
Multiple Sclerosis (Houndmills, Basingstoke, England)|January 6, 2021
An enrichment strategy for clinical trials in SPMSMarcus W Koch, Luanne Metz, Gary Cutter
Journal of Computer Assisted Tomography|July 19, 2013
National variation of technical factors in computed tomography of the headDavid Thickman, Guoqiao Wang, Jaleh White, et al.
Therapeutic Advances in Neurological Disorders|July 24, 2018
Clinical trials in multiple sclerosis: milestonesYinan Zhang, Amber Salter, Gary Cutter, et al.
Multiple Sclerosis Journal - Experimental, Translational and Clinical|September 15, 2017
Which symptoms contribute the most to patients' perception of health in multiple sclerosis?Rivka Green, Gary Cutter, Michael Friendly, et al.
Pageof 34